2015
DOI: 10.1016/j.immuni.2015.08.016
|View full text |Cite|
|
Sign up to set email alerts
|

Nociceptive Sensory Fibers Drive Interleukin-23 Production from CD301b+ Dermal Dendritic Cells and Drive Protective Cutaneous Immunity

Abstract: SUMMARY Innate resistance to Candida albicans in mucosal tissues requires the production of interleukin-17A (IL-17A) by tissue-resident cells early during infection, but the mechanism of cytokine production has not been precisely defined. In the skin, we found that dermal γδ T cells were the dominant source of IL-17A during C. albicans infection and were required for pathogen resistance. Induction of IL-17A from dermal γδ T cells and resistance to C. albicans required IL-23 production from CD301b+ dermal den-d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
279
1
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 321 publications
(287 citation statements)
references
References 80 publications
5
279
1
2
Order By: Relevance
“…Conversely, filamentous forms induced Th1 responses due to the absence of dectin-1 ligation [119]. Furthermore, the Kaplan group has shown that nociceptive sensory fibers drive IL-23 production in dermal DC, leading to the induction of IL-17 by dermal γδ T cells and subsequent activation of neutrophil antimicrobial activity, and conferring protection against C. albicans cutaneous infections [120]. …”
Section: Dendritic Cellsmentioning
confidence: 99%
“…Conversely, filamentous forms induced Th1 responses due to the absence of dectin-1 ligation [119]. Furthermore, the Kaplan group has shown that nociceptive sensory fibers drive IL-23 production in dermal DC, leading to the induction of IL-17 by dermal γδ T cells and subsequent activation of neutrophil antimicrobial activity, and conferring protection against C. albicans cutaneous infections [120]. …”
Section: Dendritic Cellsmentioning
confidence: 99%
“…There is evidence that nerve-derived CGRP induces that IL-23 release. Kashem et al [66] describe a similar pathway in which Candida albicans acts as a stimulus for CGRP release from sensory neurons, which in turn binds receptors on CD301b+ dermal dendritic cells causing release of IL-23 that then induces γδT cells to produce IL-17. This study investigated the critical role of CGRP in C. albicans immunity, as IL-17 is required for resistance to this pathogen [67, 68].…”
Section: Calcitonin Gene-related Peptidementioning
confidence: 99%
“…This study investigated the critical role of CGRP in C. albicans immunity, as IL-17 is required for resistance to this pathogen [67, 68]. They also found that ablation of sensory neurons increased susceptibility to C. albicans infection and was reversed by exogenous addition of CGRP [66]. …”
Section: Calcitonin Gene-related Peptidementioning
confidence: 99%
“…Interestingly, about 30% of psoriatic patients with traumatic spinal cord injury or surgical denervation developed local skin and nail fungal infections visible on the site below the neurological level of damage [103,105]. Since psoriasis is an IL-17-mediated disease and IL-17 immunity is required for antifungal immunity [12,106], the above clinical observations suggest that protection against fungal infections could also depend on neurogenic immunomodulation, as indirectly shown by animal studies demonstrating the function played by nociceptive sensory fibres in co-ordinating IL-17-dependent resistance to C. albicans infections [107]. Further evidence supporting the role played by neurogenic immunomodulation in human psoriasis and atopic dermatitis has been documented in histological studies describing an increased skin innervation in patients in comparison to healthy subjects, as well as an increased expression of sensory neuropeptides and their receptors on immune cells [108,109].…”
Section: Neurogenic T Cell Immunomodulationmentioning
confidence: 99%